INDV

Indivior Pharmaceuticals Inc · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-26

Figures on this page computed 2026-11-08 12:32 UTC

Last close

36.28USD

Market data, 2026-11-02

Except where said otherwise: 10-K for 2025, filed 2026-02-26

  • 21.6xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2025
    Accession
    0001628280-26-012237
    Reported in
    USD
    • computed
    • 10-K for 2025, filed 2026-02-26

    The filing itself

  • 396.9%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2025
    Accession
    0001628280-26-012237
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-26
    • 10-K for 2025, filed 2026-02-26
    • 10-K for 2025, filed 2026-02-26
    • 10-Q for 2025, filed 2026-10-29
    • 10-K for 2025, filed 2026-02-26
    • 10-Q for 2025, filed 2026-10-29

    The filing itself

  • 16.9%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001628280-26-012237
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-26
    • 10-K for 2025, filed 2026-02-26

    The filing itself

  • -7.5%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001628280-26-012237
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-26
    • 10-K for 2025, filed 2026-02-26

    The filing itself

  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2025
    Accession
    0001628280-26-012237
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-26
    • 10-Q for 2025, filed 2026-10-29

    The filing itself

  • n/aDividend yield

    The stored value is a zero that stands for missing data rather than a measurement, so we will not place it.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed
    • Computed from the filing for 2016

Ten years as a story

lens 9 of 9
2016-09-30 to 2026-11-0236.28
Its closing price: 19.45 on 2016-09-30 to 36.28 on 2026-11-02, up 87%.

Every filing we hold, oldest first

4
  1. 2025-03-03Annual report for 202210-K
  2. 2025-03-03Annual report for 202310-K
  3. 2025-03-03Annual report for 202410-K
  4. 2026-02-26Annual report for 202510-K

4 filings over the years we hold, each pinned to the day it landed.

4 filings over the years we hold, each pinned to the day it landed.

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.